IFM Investors’s Humana HUM Stock Holding History

IFM Investors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	27,762 +1,251	+5%	+$356K	0.07%	243
2026 Q1	$4.6M	Buy	26,511 +1,118	+4%	+$229K	0.04%	394
2025 Q4	$6.5M	Buy	25,393 +1,567	+7%	+$411K	0.05%	304
2025 Q3	$6.07M	Buy	23,826 +97	+0.4%	+$25.5K	0.05%	304
2025 Q2	$5.8M	Buy	23,729 +882	+4%	+$220K	0.06%	309
2025 Q1	$6.05M	Hold	22,847	–	–	0.07%	283
2024 Q4	$5.8M	Sell	22,847 -2,523	-10%	-$677K	0.06%	307
2024 Q3	$8.04M	Buy	25,370 +131	+0.5%	+$46.6K	0.08%	254
2024 Q2	$9.43M	Buy	25,239 +49	+0.2%	+$16.5K	0.1%	198
2024 Q1	$8.73M	Sell	25,190 -322	-1%	-$122K	0.1%	214
2023 Q4	$11.7M	Sell	25,512 -405	-2%	-$200K	0.14%	142
2023 Q3	$12.6M	Buy	25,917 +774	+3%	+$364K	0.17%	123
2023 Q2	$11.2M	Buy	25,143 +1,436	+6%	+$723K	0.15%	135
2023 Q1	$11.5M	Buy	23,707 +561	+2%	+$277K	0.17%	113
2022 Q4	$11.9M	Buy	23,146 +1,177	+5%	+$619K	0.2%	109
2022 Q3	$10.7M	Buy	21,969 +257	+1%	+$125K	0.19%	108
2022 Q2	$10.2M	Buy	21,712 +688	+3%	+$306K	0.18%	120
2022 Q1	$9.15M	Buy	21,024 +3,821	+22%	+$1.6M	0.14%	146
2021 Q4	$7.98M	Sell	17,203 -64	-0.4%	-$28.3K	0.15%	132
2021 Q3	$6.72M	Buy	17,267 +39	+0.2%	+$16.6K	0.14%	140
2021 Q2	$7.63M	Buy	17,228 +2,586	+18%	+$1.13M	0.16%	133
2021 Q1	$6.14M	Buy	14,642 +1,851	+14%	+$739K	0.16%	127
2020 Q4	$5.25M	Buy	12,791 +1,910	+18%	+$794K	0.17%	126
2020 Q3	$4.5M	Buy	10,881 +1,090	+11%	+$438K	0.19%	111
2020 Q2	$3.8M	Sell	9,791 -3,794	-28%	-$1.42M	0.2%	109
2020 Q1	$4.23M	Sell	13,585 -523	-4%	-$176K	0.19%	117
2019 Q4	$5.17M	Sell	14,108 -684	-5%	-$217K	0.18%	119
2019 Q3	$3.78M	Buy	14,792 +4,815	+48%	+$1.35M	0.14%	164
2019 Q2	$2.65M	Buy	9,977 +728	+8%	+$185K	0.15%	150
2019 Q1	$2.46M	Buy	9,249 +1,304	+16%	+$376K	0.16%	141
2018 Q4	$2.28M	Buy	7,945 +725	+10%	+$230K	0.18%	121
2018 Q3	$2.44M	Buy	7,220 +1,002	+16%	+$326K	0.19%	120
2018 Q2	$1.85M	Buy	6,218 +1,788	+40%	+$524K	0.17%	133
2018 Q1	$1.19M	Buy	4,430 +402	+10%	+$109K	0.17%	139
2017 Q4	$999K	Sell	4,028 -27	-0.7%	-$6.67K	0.16%	148
2017 Q3	$988K	Buy	4,055 +31	+0.8%	+$7.59K	0.17%	140
2017 Q2	$968K	Buy	4,024 +970	+32%	+$220K	0.17%	138
2017 Q1	$630K	Buy	3,054 +1,120	+58%	+$232K	0.16%	151
2016 Q4	$395K	Buy	+1,934	New	+$369K	0.19%	139

Other funds holding HUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Westwind Capital Las Cruces, New Mexico $422M AUM 17.03% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

IFM Investors's HUM Position: Q2 2026 in Review

IFM Investors increased its Humana (HUM) stake by 4.7% in Q2 2026, buying an estimated $356K and bringing the position to 27,762 shares worth $11M. The position accounts for 0.07% of the portfolio, ranked #243.

IFM Investors first reported a position in HUM in Q4 2016 and has held it in 39 quarters since. The position peaked at $12.6M in Q3 2023. 215 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

IFM Investors held 27,762 shares of Humana worth $11M as of Q2 2026.
IFM Investors bought 1,251 Humana shares in Q2 2026, an estimated $356K.
Humana made up 0.07% of IFM Investors's portfolio in Q2 2026, its #243 holding.
IFM Investors first reported a position in Humana in Q4 2016 and has held it in 39 quarters since.
IFM Investors's Humana position peaked at $12.6M in Q3 2023.
215 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.